1
|
Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.
|
Carcinogenesis
|
2012
|
1.01
|
2
|
Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors.
|
Clin Cancer Res
|
2014
|
0.99
|
3
|
Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
|
Int J Oncol
|
2006
|
0.89
|
4
|
Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.
|
Oncol Rep
|
2006
|
0.84
|
5
|
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
|
Int J Oncol
|
2006
|
0.79
|
6
|
Anti-angiogenic and anti-tumor invasive activities of tissue inhibitor of metalloproteinase-3 from shark, Scyliorhinus torazame.
|
Biochim Biophys Acta
|
2003
|
0.78
|
7
|
Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors.
|
Mol Ther
|
2006
|
0.77
|
8
|
Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
|
Int J Oncol
|
2006
|
0.77
|
9
|
3D printing of reduced graphene oxide nanowires.
|
Adv Mater
|
2014
|
0.77
|
10
|
Light propagation in conjugated polymer nanowires decoupled from a substrate.
|
Nanoscale
|
2014
|
0.75
|